Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Tuesday, November 24, 2009, 2:58pm EST - Canadian Markets close in 1 hour and 2 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
BARR PHARMA INC (BRL)
On Nov 17:
64.81 USD
0.00 (0.00%)
MORE ON BRL
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
BARR PHARMA INC
(NYSE:BRL) Delayed quote data
Last Trade:
64.81 USD
Trade Time:
Nov 17
Change:
0.00 (0.00%)
Prev Close:
64.81
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
65.75
Day's Range:
N/A - N/A
52wk Range:
37.40 - 68.35
Volume:
0
Avg Vol
(3m)
:
3,000,180
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Free Annual Reports
Add BRL to Portfolio
Download Data
HEADLINES
[video] Guitar Hero 5 Lifts Activision
at Forbes.com
(Fri, Aug 28)
BioDelivery Doesn't Stop With Onsolis Approval
at TheStreet.com
(Mon, Jul 27)
This Just In: Upgrades and Downgrades
at Motley Fool
(Tue, Jan 6)
BARR PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online
(Tue, Dec 23)
Stocks in the Black in 2008: The Few That Bucked the Trend
at Motley Fool
(Fri, Dec 19)
[video] Am I Diversified?
at CNBC
(Wed, Dec 17)
Double Down on Top Stocks
at Motley Fool
(Fri, Dec 5)
In Pictures: 11 Winning Stocks
at Forbes.com
(Wed, Dec 3)
The S&P's Winning Stocks
at Forbes.com
(Wed, Dec 3)
Cephalon Lashes Out At Copycats
at Forbes.com
(Wed, Nov 26)
More Headlines for BRL...
ANALYST
EPS Est (next year)
(Dec-08)
:
N/A
EPS Est (in 2 years)
(Dec-09)
:
N/A
Avg Rec (current)*:
2.4
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
No business summary available for BRL.
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices